Skip to content

Collegium Pharmaceutical, Inc. COLL Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)

Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five) at other companies

Kadant logo
KadantKAI
$174.06M+28.8%
Financial Institutions logo
Financial InstitutionsFISI
$484K-29.2%
Clarivate logo
ClarivateCLVT
$4.76B
OceanFirst Financial logo
OceanFirst FinancialOCFC
$212K-67.0%
First Commonwealth Financial logo
First Commonwealth FinancialFCF
$0-100%
Rumble, Inc. logo
Rumble, Inc.RUM
$293.74K-35.0%

Segments

By product

See full
Jornay Pm$104.78M-44.4%
Symproic and other$6.07M

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×